Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News

Table of Contents

Highlights

  • Highlights
    Highlights of This Issue
    Mol Cancer Res March 1 2017 15 (3) 235-235;

Cell Cycle and Senescence

  • Cell Cycle and Senescence
    Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth
    Xiangnan Guan, Kyle M. LaPak, Rebecca C. Hennessey, Christina Y. Yu, Reena Shakya, Jianying Zhang and Christin E. Burd
    Mol Cancer Res March 1 2017 15 (3) 237-249; DOI:10.1158/1541-7786.MCR-16-0319

Cell Death and Survival

  • Cell Death and Survival
    Autophagy Inhibition Enhances Sunitinib Efficacy in Clear Cell Ovarian Carcinoma
    Lindsay DeVorkin, Matthew Hattersley, Paul Kim, Jenna Ries, Jaeline Spowart, Michael S. Anglesio, Samuel M. Levi, David G. Huntsman, Ravi K. Amaravadi, Jeffrey D. Winkler, Anna V. Tinker and Julian J. Lum
    Mol Cancer Res March 1 2017 15 (3) 250-258; DOI:10.1158/1541-7786.MCR-16-0132

  • Cell Death and Survival | AuthorChoice
    Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade
    Michelle M. Williams, Linus Lee, Donna J. Hicks, Meghan M. Joly, David Elion, Bushra Rahman, Courtney McKernan, Violeta Sanchez, Justin M. Balko, Thomas Stricker, Monica Valeria Estrada and Rebecca S. Cook
    Mol Cancer Res March 1 2017 15 (3) 259-268; DOI:10.1158/1541-7786.MCR-16-0280-T

DNA Damage and Repair

  • DNA Damage and Repair
    DNA Polymerase Beta Germline Variant Confers Cellular Response to Cisplatin Therapy
    Antonia A. Nemec, Laura Abriola, Jane S. Merkel, Elisa de Stanchina, Michelle DeVeaux, Daniel Zelterman, Peter M. Glazer and Joann B. Sweasy
    Mol Cancer Res March 1 2017 15 (3) 269-280; DOI:10.1158/1541-7786.MCR-16-0227-T

Genomics

  • Genomics
    Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment
    Lisa Staunton, Claire Tonry, Rosina Lis, Virginia Espina, Lance Liotta, Rosanna Inzitari, Michaela Bowden, Aurelie Fabre, John O'Leary, Stephen P. Finn, Massimo Loda and Stephen R. Pennington
    Mol Cancer Res March 1 2017 15 (3) 281-293; DOI:10.1158/1541-7786.MCR-16-0358

Oncogenes and Tumor Suppressors

  • Oncogenes and Tumor Suppressors | AuthorChoice
    LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell–like Transcriptional Program in AML
    Jianbiao Zhou, Zit-Liang Chan, Chonglei Bi, Xiao Lu, Phyllis S.Y. Chong, Jing-Yuan Chooi, Lip-Lee Cheong, Shaw-Cheng Liu, Ying Qing Ching, Yafeng Zhou, Motomi Osato, Tuan Zea Tan, Chin Hin Ng, Siok-Bian Ng, Shi Wang, Qi Zeng and Wee-Joo Chng
    Mol Cancer Res March 1 2017 15 (3) 294-303; DOI:10.1158/1541-7786.MCR-16-0275-T

  • Oncogenes and Tumor Suppressors
    Predictive Outcomes for HER2-enriched Cancer Using Growth and Metastasis Signatures Driven By SPARC
    Leandro N. Güttlein, Lorena G. Benedetti, Cristóbal Fresno, Raúl G. Spallanzani, Sabrina F. Mansilla, Cecilia Rotondaro, Ximena L. Raffo Iraolagoitia, Edgardo Salvatierra, Alicia I. Bravo, Elmer A. Fernández, Vanesa Gottifredi, Norberto W. Zwirner, Andrea S. Llera and Osvaldo L. Podhajcer
    Mol Cancer Res March 1 2017 15 (3) 304-316; DOI:10.1158/1541-7786.MCR-16-0243-T

  • Oncogenes and Tumor Suppressors
    Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations
    Tyler M. Foley, Susan N. Payne, Cheri A. Pasch, Alex E. Yueh, Dana R. Van De Hey, Demetra P. Korkos, Linda Clipson, Molly E. Maher, Kristina A. Matkowskyj, Michael A. Newton and Dustin A. Deming
    Mol Cancer Res March 1 2017 15 (3) 317-327; DOI:10.1158/1541-7786.MCR-16-0256

  • Oncogenes and Tumor Suppressors
    Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation
    Xiaolei Xie, Guangan He and Zahid H. Siddik
    Mol Cancer Res March 1 2017 15 (3) 328-339; DOI:10.1158/1541-7786.MCR-16-0257-T

Signal Transduction

  • Signal Transduction
    Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors
    Monica E. Wielgos, Rajani Rajbhandari, Tiffiny S. Cooper, Shi Wei, Susan Nozell and Eddy S. Yang
    Mol Cancer Res March 1 2017 15 (3) 340-347; DOI:10.1158/1541-7786.MCR-16-0287-T

  • Signal Transduction
    Nuclear Import of JAK1 Is Mediated by a Classical NLS and Is Required for Survival of Diffuse Large B-cell Lymphoma
    Fen Zhu, Byounghoon Hwang, Shigeki Miyamoto and Lixin Rui
    Mol Cancer Res March 1 2017 15 (3) 348-357; DOI:10.1158/1541-7786.MCR-16-0344

Retraction

  • Retraction | Free Article
    Retraction: Nek6 Mediates Human Cancer Cell Transformation and Is a Potential Cancer Therapeutic Target
    Mol Cancer Res March 1 2017 15 (3) 358-358; DOI:10.1158/1541-7786.MCR-16-0440

Back to top
PreviousNext
Molecular Cancer Research: 15 (3)
March 2017
Volume 15, Issue 3
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by Author
  • Editorial Board (PDF)

Sign up for alerts

Issue Highlights

  • Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade
  • Stromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth
  • Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations
  • Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors

Jump to

  • Highlights
  • Cell Cycle and Senescence
  • Cell Death and Survival
  • DNA Damage and Repair
  • Genomics
  • Oncogenes and Tumor Suppressors
  • Signal Transduction
  • Retraction
Advertisement
  • Most Cited
  • Most Read
Loading
  • Primary Cilia Loss Promotes Aggressive Breast Cancer
  • Characterization of a TGFβ-Induced EMT Signature
  • Interaction between MELK and EZH2 in Medulloblastoma
  • HuR Is a Promising Target in GI Cancers
  • 20q Amplification in Colon Cancer
More...
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement